Basics |
Company: |
Aptose Biosciences, Inc. |
IPO Date: |
April 1, 1992 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$10.83M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.10 | 3.58%
|
Avg Daily Range (30 D): |
$0.01 | 4.62%
|
Avg Daily Range (90 D): |
$0.01 | 5.02%
|
Institutional Daily Volume |
Avg Daily Volume: |
.22M |
Avg Daily Volume (30 D): |
4.02M |
Avg Daily Volume (90 D): |
4.93M |
Trade Size |
Avg Trade Size (Sh.): |
105 |
Avg Trade Size (Sh.) (30 D): |
955 |
Avg Trade Size (Sh.) (90 D): |
1,066 |
Institutional Trades |
Total Inst.Trades: |
16 |
Avg Inst. Trade: |
$1.04M |
Avg Inst. Trade (30 D): |
$M |
Avg Inst. Trade (90 D): |
$M |
Avg Inst. Trade Volume: |
.03M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$M |
Avg Closing Trade (30 D): |
$M |
Avg Closing Trade (90 D): |
$M |
Avg Closing Volume: |
K |
|
|
|
|
Financials |
|
TTM |
Q3 2024 |
Q2 2024 |
Basic EPS
|
$-3.05
|
$-.37
|
$-.43
|
Diluted EPS
|
$-3.05
|
$-.37
|
$-.43
|
Revenue
|
$ M
|
$ M
|
$ M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -35.8M
|
$ -6.95M
|
$ -7.25M
|
Operating Income / Loss
|
$
|
$
|
$
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -7.39M
|
$ M
|
$ .99M
|
PE Ratio
|
|
|
|
Splits |
Jun 06, 2023:
15:1
|
Oct 06, 2014:
12:1
|
Jun 01, 2010:
30:1
|
|